Under 503B, a bulk drug substance generally must appear on the 503B Bulks List or be connected to a drug product appearing on FDAs drug shortage list at the relevant time
Where applicable, as we discuss each aspect of different peptide therapies, we start with a high-altitude view and then zoom in on the caveats and exceptions that make them unique
This pathway: Promotes synaptogenesis the formation of new synaptic connections between neurons Mimics BDNF activity downstream effects on neuronal survival, plasticity, and growth Enhances hippocampal function the hippocampus is critical for memory formation and retrieval Crosses the blood-brain barrier unlike BDNF itself, Dihexa is small enough to penetrate the BBB The result is enhanced neural plasticity the brain's ability to reorganize and form new connections, which underlies learning, memory, and cognitive performance
These peptides lack human safety data, have unknown long-term effects, cannot be legally prescribed, and are often contaminated when sourced from gray-market suppliers
"Groundwater level observations in 250,000 coastal US wells reveal scope of potential seawater intrusion"